Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasper Lamberth

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Nature Immunology|May 5, 2009
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominanceStefan Tenzer, Edmund Wee, Anne Burgevin, et al.
The AAPS Journal|June 2, 2023
Survey Outcome on Immunogenicity Risk Assessment Tools for Biotherapeutics: an Insight into Consensus on Methods, Application, and Utility in Drug DevelopmentJochem Gokemeijer, Yi Wen, Vibha Jawa, et al.
Pharmaceutical Research|October 8, 2024
Impact of Manufacturing Process and Compounding on Properties and Quality of Follow-On GLP-1 Polypeptide DrugsMorten Hach, Dorthe Kot Engelund, Simon Mysling, et al.
Journal of Medicinal Chemistry|July 16, 2024
Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 AnalogKristian Sass-Ørum, Tina Møller Tagmose, Jørgen Olsen, et al.
Blood|June 2, 2021
A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A miceHenrik Østergaard, Jacob Lund, Per J Greisen, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Nature Immunology|May 5, 2009
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominanceStefan Tenzer, Edmund Wee, Anne Burgevin, et al.
The AAPS Journal|June 2, 2023
Survey Outcome on Immunogenicity Risk Assessment Tools for Biotherapeutics: an Insight into Consensus on Methods, Application, and Utility in Drug DevelopmentJochem Gokemeijer, Yi Wen, Vibha Jawa, et al.
Pharmaceutical Research|October 8, 2024
Impact of Manufacturing Process and Compounding on Properties and Quality of Follow-On GLP-1 Polypeptide DrugsMorten Hach, Dorthe Kot Engelund, Simon Mysling, et al.
Journal of Medicinal Chemistry|July 16, 2024
Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 AnalogKristian Sass-Ørum, Tina Møller Tagmose, Jørgen Olsen, et al.
Blood|June 2, 2021
A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A miceHenrik Østergaard, Jacob Lund, Per J Greisen, et al.
Pageof 4